Acupressure for Cancer
Trial Summary
What is the purpose of this trial?
This clinicaI trial is being done to determine if acupressure is helpful to reduce anxiety related to chemotherapy, compared with "sham" (or placebo) acupressure in patients with cancer. Anxiety, experienced by many patients with cancer, can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicine ways to manage symptoms. Acupressure is the application of non-invasive finger pressure along energy points throughout the body in order to relieve pain and induce a feeling of well-being. Previous research has shown that acupressure can help both adults and children with their anxiety in certain situations, such as after surgery. Patients can be taught how to do the acupressure on themselves, making this an intervention that can be done anywhere. Acupressure is well tolerated with minimal reports of adverse reactions. Undergoing acupressure may be effective in reducing anxiety in cancer patients receiving chemotherapy.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on adding acupressure as a way to manage anxiety, so you may not need to stop your medications, but it's best to confirm with the trial organizers.
What data supports the effectiveness of the treatment Acupressure for Cancer?
Is acupressure safe for cancer patients?
How is the treatment acupressure unique for cancer patients?
Acupressure is unique for cancer patients because it offers a non-invasive way to manage symptoms like pain, depression, and nausea without the use of needles, making it a safer option for those concerned about immunosuppression. It can be self-administered, even virtually, which is particularly beneficial when access to in-person care is limited.347910
Research Team
Elizabeth Cathcart-Rake
Principal Investigator
Mayo Clinic in Rochester
Eligibility Criteria
This trial is for cancer patients experiencing anxiety during chemotherapy. It's exploring if acupressure, a non-invasive pressure technique, can help manage their symptoms. Participants should be interested in non-medication treatments and willing to learn self-administered techniques.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either true or sham acupressure for 10 minutes on study, followed by self-administration sessions at home at least twice daily for seven days
Follow-up
Participants are monitored for changes in anxiety-related symptoms using questionnaires
Treatment Details
Interventions
- Acupressure
Acupressure is already approved in United States, European Union for the following indications:
- Relief from aromatase inhibitor-associated musculoskeletal symptoms in breast cancer patients
- Complementary therapy for symptom management in cancer patients, including relief from aromatase inhibitor-associated musculoskeletal symptoms
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor